Solos Endoscopy’s MammoView(R) Now for use with Low Temperature Sterilization System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WESTPORT, CT / ACCESSWIRE / September 16, 2020 / Solos Endoscopy, Inc. (OTC PINK:SNDY) is pleased to announce it has completed the compatibility testing of its MammoView product line with The STERIS V-PRO 1 Low Temperature Sterilization System.

“Solos Endoscopy continues to strive and provide the latest reprocessing methods for its customers.”, stated Dominick Gatto, Chief Executive Officer. “In response to our customer’s needs, we had our MammoView products tested for compatibility with the STERIS V-PRO Low Temperature Sterilization System.” said Gatto. He further stated, “we are confident this additional sterilization method will expand our customer reach and enhance the efficiency of the MammoView products for our customers”.

Solos MammoView Breast Endoscopy System employs advanced microendoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where most of the breast cancers arise. Mammary ductoscopy is designed to provide physicians the means to detect, diagnose, and treat breast disease years before surgery, physical exams or other external imaging can reveal evidence of the disease.

About Solos Endoscopy, Inc.: Solos Endoscopy Inc. has long provided quality healthcare instruments to Hospitals across the United States. For more than 30 Years, from medical schools to hospitals, surgeons have relied on Solos Endoscopy to develop medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Additional information on its line of products is available on the Company’s website at: www.solosendoscopy.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding the potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company’s Annual Report filing and other filings with the OTC Markets Group (available at www.otcmarkets.com). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

CONTACT:

Solos Endoscopy, Inc.
Investor Relations
(617) 360-9700

SOURCE: Solos Endoscopy, Inc.

View source version on accesswire.com:
https://www.accesswire.com/606062/Solos-Endoscopys-MammoViewR-Now-for-use-with-Low-Temperature-Sterilization-System

Staff

Recent Posts

SmartSKN Launches K-OWN: The World’s first AI custom Korean skincare platform powered by robots

BOSTON, March 14, 2025 /PRNewswire/ -- SmartSKN, a leader in K-Beauty technology, announces the launch…

11 hours ago

Nimblemind.ai Raises $2.5M to Unlock AI-Ready Clinical Data for Healthcare Providers

CHICAGO, March 14, 2025 /PRNewswire/ -- Nimblemind.ai, an AI-powered data infrastructure platform designed to help…

11 hours ago

AI-Powered Healthcare: How ADLINK’s Medical Innovations at HIMSS 2025 Are Transforming Patient Care

Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Summary: Successful Showcase:…

11 hours ago

CTG Appoints Dan Stoke Vice President of U.S. Healthcare Business

Growth-Oriented Healthcare IT Leader to Build on CTG’s Strong Industry Legacy; Drive Growth, Innovation, and…

13 hours ago

TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate…

13 hours ago

WTWH Healthcare, a WTWH Media Company, Announces 2025 Aspect Awards Winners

CLEVELAND, March 14, 2025 /PRNewswire/ -- WTWH Healthcare, a WTWH Media company, is proud to…

17 hours ago